Interim Results for the six months ended 30 September 2011. The second half has started well. Based on orders booked for delivery in the third quarter, total sales after nine months should be comfortably ahead of last year. The approval for Aivlosin® in Canada is another important step in the Company’s global marketing plans; sales will commence after the end of the current financial year.
Get more information at
www.businesswire.com/news/home/20111211005001/en/Eco-Animal-Health-UK-Regulatory-Announcement-Half-yearly
No comments:
Post a Comment